Flagship Pioneering Special Opportunities Fund II, L.P.
Insider CIK 1761283 · SGTX 10% owner · FHTX Director, 10% owner · OMGA 10% owner · GENB 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,265,822 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 843,881 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,500,000 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 17,016,215 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 18,483,785 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,109,704 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 1,265,822 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,531,644 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,109,704 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion deriv | 2026-03-02 | 2026-03-02 | 2,953,586 | — | $0 | 0 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 13,702,224 | — | $0 | 13,702,224 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 987,491 | — | $0 | 987,491 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 2,777,752 | — | $0 | 2,777,752 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 2,777,752 | — | $0 | 2,777,752 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 15,264,724 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 4,340,252 | SEC↗ |
| GENB Generate Biomedicines, Inc | P Buy | 2026-03-02 | 2026-03-02 | 1,562,500 | $16.00 | $25.00M | 1,562,500 | SEC↗ |
| GENB Generate Biomedicines, Inc | C Conversion | 2026-03-02 | 2026-03-02 | 12,723,940 | — | $0 | 12,723,940 | SEC↗ |
| GENB Generate Biomedicines, Inc | A Award deriv | 2026-02-26 | 2026-03-02 | 29,561 | — | $0 | 29,561 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 2,235,468 | $6.71 | $15.00M | 2,235,468 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 1,117,734 | — | $0 | 1,117,734 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | A Award deriv | 2026-01-13 | 2026-01-15 | 1,117,734 | — | $0 | 1,117,734 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy deriv | 2024-05-22 | 2024-05-24 | 1,814,915 | $5.51 | $10.00M | 1,814,915 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy deriv | 2024-05-22 | 2024-05-24 | 1,814,914 | $5.51 | $10.00M | 1,814,914 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | U Tender | 2023-08-11 | 2023-08-15 | 683,760 | $14.92 | $10.20M | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | U Tender | 2023-08-11 | 2023-08-15 | 113,960 | $14.92 | $1.70M | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2023-02-27 | 2023-02-27 | 1,993,986 | $5.78 | $11.53M | 7,508,693 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2023-02-27 | 2023-02-27 | 1,329,324 | $5.78 | $7.68M | 1,329,324 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 13,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 2,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,667 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 22,275,232 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 4,112,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 5,000,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 1,666,666 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 3,333,333 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion deriv | 2021-08-03 | 2021-08-05 | 27,388,000 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 970,588 | — | $0 | 970,588 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,323,529 | — | $0 | 1,323,529 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 661,764 | $17.00 | $11.25M | 5,514,707 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 4,852,943 | — | $0 | 4,852,943 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 294,117 | $17.00 | $5.00M | 1,617,646 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | P Buy | 2021-08-03 | 2021-08-05 | 220,588 | $17.00 | $3.75M | 8,617,413 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 8,396,825 | — | $0 | 8,396,825 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 5,896,386 | — | $0 | 5,896,386 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | C Conversion | 2021-08-03 | 2021-08-05 | 1,088,470 | — | $0 | 1,088,470 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 4,444,444 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 1,481,481 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 370,370 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 4,074,074 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion | 2020-12-08 | 2020-12-10 | 8,888,888 | — | $0 | 8,888,888 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion | 2020-12-08 | 2020-12-10 | 1,481,481 | — | $0 | 1,481,481 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 2,666,666 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 1,336,293 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 3,333,333 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 8,333,333 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion deriv | 2020-10-27 | 2020-10-29 | 7,500,000 | — | $0 | 0 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 9,330,878 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 4,504,504 | — | $0 | 8,558,558 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 4,054,054 | — | $0 | 4,054,054 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 1,441,441 | — | $0 | 1,441,441 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 1,491,441 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 722,320 | — | $0 | 9,280,878 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | C Conversion | 2020-10-27 | 2020-10-29 | 1,801,801 | — | $0 | 1,801,801 | SEC↗ |
| FHTX Foghorn Therapeutics Inc. | P Buy | 2020-10-27 | 2020-10-29 | 50,000 | $16.00 | $800.0K | 1,851,801 | SEC↗ |